Autonomix Medical (AMIX) Other financing activities (2023 - 2025)

Autonomix Medical's (AMIX) quarterly Other financing activities came in at $4.5 in Q4 2025, down 100.0% on a QoQ basis from $1.1 million in Q1 2025.

Autonomix Medical (AMIX) Other financing activities (2023 - 2025) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Other financing activities data on file, last reported at $4.5 in Q4 2025.

On a quarterly basis, Other financing activities changed N/A year-over-year to $4.5 in Q4 2025; TTM through Dec 2025 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 million, up 90.64% from the prior year.
Other financing activities for Q4 2025 stood at $4.5, down from $1.1 million in the prior quarter.
Over the last five years, Other financing activities for AMIX reached as high as $1.1 million in Q1 2025 and fell as low as -$346000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Autonomix Medical	1.03 Mn	1.03 Mn	-

Download Data